Board Meeting17 Sept 2026, 04:50 pm
Biogen Pharmachem Trading Window Closed for Q2 Results
AI Summary
Biogen Pharmachem Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, October 1, 2026, and will continue until 48 hours after the declaration of the unaudited financial results for the second quarter ended September 30, 2026. The specific date for the Board Meeting to consider these results will be communicated later.
Key Highlights
- Trading window closed for Biogen Pharmachem securities.
- Closure effective from October 1, 2026.
- Window reopens 48 hours after Q2 financial results announcement.
- Board meeting date for results to be announced separately.
Price Impact
More from BIOGEN